Terms: = Head and neck cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
306 results:
1. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract] [Full Text] [Related]
2. machine learning-based survival prediction nomogram for postoperative parotid mucoepidermoid carcinoma.
Huang Z; Chen Z; Li Y; Lin T; Cai S; Wu W; Wu L; Xu S; Lu J; Qiu S
Sci Rep; 2024 Apr; 14(1):7686. PubMed ID: 38561379
[TBL] [Abstract] [Full Text] [Related]
3. Genomic alterations in oral multiple primary cancers.
Zhou X; Cai X; Jing F; Li X; Zhang J; Zhang H; Li T
Int J Oral Sci; 2024 Feb; 16(1):13. PubMed ID: 38368361
[TBL] [Abstract] [Full Text] [Related]
4. Gastric adenocarcinoma and periodontal disease: A systematic review and meta-analysis.
Aguiar FJN; Menezes FDS; Fagundes MA; Fernandes GA; Alves FA; Filho JG; Curado MP
Clinics (Sao Paulo); 2024; 79():100321. PubMed ID: 38301538
[TBL] [Abstract] [Full Text] [Related]
5. An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
Gao Y; Wang W; Yang Y; Xu Z; Lin Y; Lang T; Lei S; Xiao Y; Yang W; Huang W; Li Y
BMC Cancer; 2024 Jan; 24(1):69. PubMed ID: 38216936
[TBL] [Abstract] [Full Text] [Related]
6. Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma.
Wang J; Zhang X; Gan T; Rao NN; Deng K; Yang JL
World J Gastroenterol; 2023 Dec; 29(47):6138-6147. PubMed ID: 38186680
[TBL] [Abstract] [Full Text] [Related]
7. Development of a nomogram for predicting pharyngocutaneous fistula based on skeletal muscle mass and systemic inflammation indices.
Wu C; Yan X; Xie F; Lai X; Wang L; Jiang Y
Head Neck; 2024 Mar; 46(3):571-580. PubMed ID: 38124665
[TBL] [Abstract] [Full Text] [Related]
8. A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.
Zhang M; Chen Y; Wu W; Jin F; Li Y; Long J; Luo X; Gong X; Chen X; Liu L; Tang H; Wang Z
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18081-18091. PubMed ID: 37985501
[TBL] [Abstract] [Full Text] [Related]
9. Season of radiotherapy and outcomes of head & neck cancer patients in the mach-NC & MARCH meta-analyses.
Limkin E; Blanchard P; Lacas B; Bourhis J; Parmar M; Licitra L; Le QT; Yom SS; Fortpied C; Langendijk J; Vermorken JB; Bernier J; Overgaard J; Harris J; Pignon JP; Auperin A;
Radiother Oncol; 2024 Jan; 190():110011. PubMed ID: 37956890
[TBL] [Abstract] [Full Text] [Related]
10. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
[TBL] [Abstract] [Full Text] [Related]
11. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
12. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
[TBL] [Abstract] [Full Text] [Related]
13. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
[TBL] [Abstract] [Full Text] [Related]
14. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract] [Full Text] [Related]
15. Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
[TBL] [Abstract] [Full Text] [Related]
16. Caspase activation in tumour-infiltrating lymphocytes is associated with lymph node metastasis in oral squamous cell carcinoma.
Bhosale PG; Kennedy RA; Watt FM
J Pathol; 2023 Sep; 261(1):43-54. PubMed ID: 37443405
[TBL] [Abstract] [Full Text] [Related]
17. Genome sequencing reveals molecular subgroups in oral epithelial dysplasia.
Márquez A; Mujica I; Jordan N; Baez P; Tarquinio S; Nunes J; Adorno D; Martínez B; Morales-Pison S; Fernandez-Ramires R
Braz Oral Res; 2023; 37():e063. PubMed ID: 37341234
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract] [Full Text] [Related]
19. Value of clinical features combined with multimodal ultrasound in predicting lymph node metastasis in cervical central area of papillary thyroid carcinoma.
Xue J; Li S; Qu N; Wang G; Chen H; Wu Z; Cao X
J Clin Ultrasound; 2023 Jun; 51(5):908-918. PubMed ID: 37058552
[TBL] [Abstract] [Full Text] [Related]
20. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
[Next]
